While many extoll the potential contribution of risk assessment to reducing the human and fiscal costs of mass incarceration without increasing crime, others adamantly oppose the incorporation of risk assessment in sanctioning. The principal concern is that any benefits in terms of reduced rates of incarceration achieved through the use of risk assessment will be offset by costs to social justice-which are claimed to be inherent in any risk assessment process that relies on variables for which offenders bear no responsibility, such as race, gender, and age. Previous research has addressed the variables of race and gender. Here, based on a sample of 7,350 federal offenders, we empirically test the predictive fairness of an instrument-the Post Conviction Risk Assessment (PCRA)-that includes the variable of age. We found that the strength of association between PCRA scores and future arrests was similar across younger (i.e., 25 years and younger), middle (i.e., 26-40 years), and older (i.e., 41 years and older) age groups (AUC values .70 or higher). Nevertheless, rates of arrest within each PCRA risk category were consistently lower for older than for younger offenders. Despite its inclusion of age as a risk factor, PCRA scores overestimated rates of recidivism for older offenders and underestimated rates of recidivism for younger offenders. (PsycINFO Database Record

Download full-text PDF

Source
http://dx.doi.org/10.1037/lhb0000233DOI Listing

Publication Analysis

Top Keywords

risk assessment
24
age risk
8
assessment sanctioning
8
race gender
8
pcra scores
8
years older
8
younger offenders
8
rates recidivism
8
risk
7
assessment
6

Similar Publications

Early developmental trajectories of the impaired hand in infants with unilateral cerebral palsy.

Dev Med Child Neurol

January 2025

Queensland Cerebral Palsy and Rehabilitation Research Centre, Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Aim: To identify developmental trajectories of impaired hand function in infants aged 3 to 15 months with unilateral cerebral palsy (CP).

Method: Sixty-three infants (37 male; median gestational age 37 weeks [interquartile range 30-39.1 weeks]) recruited as part of a randomized trial with a confirmed diagnosis of unilateral CP were included.

View Article and Find Full Text PDF

Objective: Development of postpartum depressive symptoms (PDS) is influenced by many social determinants of health, including income, discrimination, and other stressful life experiences. Early recognition of PDS is essential to reduce its long-term impact on mothers and their children, but postpartum checkups are highly underutilized. This study examined how stressful life experiences and race-based discrimination influence PDS development and whether or not a women has a postpartum checkup.

View Article and Find Full Text PDF

Purpose Of Review: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, characterized by hepatic steatosis with at least one cardiometabolic risk factor. Patients with MASLD are at increased risk for the occurrence of cardiovascular events. Within this review article, we aimed to provide an update on the pathophysiology of MASLD, its interplay with cardiovascular disease, and current treatment strategies.

View Article and Find Full Text PDF

The rapid development and deployment of mRNA and non-mRNA COVID-19 vaccines have played a pivotal role in mitigating the global pandemic. Despite their success in reducing severe disease outcomes, emerging concerns about cardiovascular complications have raised questions regarding their safety. This systematic review critically evaluates the evidence on the cardiovascular effects of COVID-19 vaccines, assessing both their protective and adverse impacts, while considering the challenges posed by the limited availability of randomized controlled trial (RCT) data on these rare adverse events.

View Article and Find Full Text PDF

Introduction: Obesity and its complications are associated with high morbidity/mortality and a significant healthcare cost burden in Spain. It is therefore essential to know the potential clinical and economic benefits of reducing obesity. The objective of this study is to predict the decrease in rates of onset of potential complications associated with obesity and the cost savings after a weight loss of 15% over 10 years in Spain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!